The latest closing stock price for Neuphoria Therapeutics as of January 07, 2025 is 3.57.
An investor who bought $1,000 worth of Neuphoria Therapeutics stock at the IPO in 2021 would have $-758 today, roughly -1 times their original investment - a -37.65% compound annual growth rate over 3 years.
The all-time high Neuphoria Therapeutics stock closing price was 14.73 on December 16, 2021.
The Neuphoria Therapeutics 52-week high stock price is 10.50, which is 194.1% above the current share price.
The Neuphoria Therapeutics 52-week low stock price is 0.18, which is 95% below the current share price.
The average Neuphoria Therapeutics stock price for the last 52 weeks is 0.84.
An investor who bought $1,000 worth of Neuphoria Therapeutics stock at the IPO in 2021 would have $-758 today, roughly -1 times their original investment - a -37.65% compound annual growth rate over 3 years.
The all-time high Neuphoria Therapeutics stock closing price was 14.73 on December 16, 2021.
The Neuphoria Therapeutics 52-week high stock price is 10.50, which is 194.1% above the current share price.
The Neuphoria Therapeutics 52-week low stock price is 0.18, which is 95% below the current share price.
The average Neuphoria Therapeutics stock price for the last 52 weeks is 0.84.